Author:
Zuo Hua-li,Lin Yang-Chi-Dung,Huang Hsi-Yuan,Wang Xu,Tang Yun,Hu Yuan-jia,Kong Xiang-jun,Chen Qian-jun,Zhang Yu-zhu,Hong Hsiao-Chin,Li Jing,Hu Si-yao,Huang Hsien-Da
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference16 articles.
1. Chen RC, Sang L, Jiang M, Yang ZW, Jia N, Fu WY, et al. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020;146:89–100.
2. Zhang Y, Xiao M, Zhang SL, Xia P, Cao W, Jiang W, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382:e38.
3. Ramlall V, Thangaraj PM, Meydan C, Foox J, Butler D, Kim J, et al. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nat Med. 2020;26:1609–15.
4. Chan NC, Weitz JI. COVID-19 coagulopathy, thrombosis, and bleeding. Blood. 2020;136:381–3.
5. Li XB, Liu R, Wang Z, Wu MW, Chang L, Yuan HW, et al. MicroRNA-7 regulates the proliferation and metastasis of human papillary carcinoma cells by targeting Bcl-2. Am J Transl Res. 2020;12:5772–80.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献